These lines were chosen for comparative studies with the ER−, E-cadherin + Mary-X because, when grown as xenografts, the MCF-7 and the MDA-MB-231 lines did not manifest lymphovascular invasion or tumor emboli formation within lymphovascular spaces. The gene discussed is CDH1; the disease is neoplasm.